Angelika Joos,
MPharm

Ms. Joos is responsible for Regulatory Policy issues within Merck Sharp & Dohme's Global Regulatory Affairs department since 2001 and heads their European Union office in Brussels. Over the past 18 years, she has gained strategic, as well as operational, experience with all regulatory procedures and various products in different therapeutic areas.

In her current position as Executive Director, Global Regulatory Policy, she is responsible for monitoring and implementing Regulatory Policies & Procedures and advising the company on Regulatory strategies. In this capacity she oversees activities in Europe, Middle East, Africa, and Asia-Pacific and actively identifies opportunities that align with Merck Sharp & Dohme's business priorities.

Ms. Joos has over ten years of experience in working with various trade associations and professional organizations. At the European Union level, she represents Merck Sharp & Dohme in various Committees of the European Federation of Pharmaceutical Industries & Associations and EuropaBio, and is also actively involved in international policy activities as the Merck Sharp & Dohme delegate in the International Federation of Pharmaceutical Manufacturers & Associations Regulatory & Technical Policy Committee. She was member, and later chair, of the DIA Advisory Council Europe from 2008 – 2015 and joined the DIA Board of Directors in 2014. Ms. Joos' main interests are related to clinical trials, health technology assessment, pediatrics, and patient involvement.